Finance

Beta
Mga Listahan
Mga sektor ng equity
Mga Simbolo
Mga Simbolo
Presyo
Palitan
% ng Pagbabago
Trend
Nakaraang Pagsara
Buksan
Mataas
Mababa
Dami
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.99%
1,093.81
+10.77
+0.99%
1,083.041,082.631,099.011,080.59
SIXC
Communications
SIXC
Communications
SIXC
+1.06%
608.77
+6.39
+1.06%
602.38602.38609.75599.75
SIXE
Energy
SIXE
Energy
SIXE
+0.96%
1,254.81
+11.98
+0.96%
1,242.831,229.311,258.881,220.51
SIXI
Industrials
SIXI
Industrials
SIXI
+2.76%
1,761.11
+47.29
+2.76%
1,713.821,715.471,763.111,715.47
SIXM
Financials
SIXM
Financials
SIXM
+0.40%
642.58
+2.59
+0.40%
639.99636.98644.04631.81
SIXR
Staples
SIXR
Staples
SIXR
+1.63%
851.13
+13.67
+1.63%
837.46840.30852.55840.30
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.76%
217.98
+3.76
+1.76%
214.22214.22218.25214.05
SIXT
Technology
SIXT
Technology
SIXT
+0.23%
3,211.83
+7.45
+0.23%
3,204.383,215.043,217.443,159.90
SIXU
Utilities
SIXU
Utilities
SIXU
+2.55%
948.98
+23.60
+2.55%
925.38927.91949.76927.91
SIXV
Health care
SIXV
Health care
SIXV
+2.20%
1,474.52
+31.81
+2.20%
1,442.711,443.011,477.901,443.01
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1.30%
2,392.12
+30.78
+1.30%
2,361.342,391.002,399.182,354.52
FLNA:BMV
Filana Therapeutics Inc
MX$28.00
0.00%
(0.00) 1D
Abr 29, 12:17:30 PM GMT-6  ·   MXN
Lahat ng simbolo
SimboloPresyoPalitan% ng Pagbabago
Bumubuo ng mga nangungunang insight para sa FLNA...
Mkt. cap
70.05M
Avg. na dami
13.00
Dami
0.00
Mataas nang 52-wk
MX$56.00
Mababa nang 52-wk
MX$28.00
Bilang ng mga empleyado
19
Mga balita at kwento
Mula sa mga source sa buong web
Profile
Filana Therapeutics, Inc. is an American pharmaceutical company based in Austin, Texas. The company was developing simufilam, an oral-tablet drug candidate for the treatment of Alzheimer's disease. Development of simufilam was discontinued in November 2024 after it failed to show clinical benefit in phase III clinical trials. In June 2024, the United States Department of Justice charged an advisor to company, Hoau-Yan Wang, with fraud over research results related to the experimental drug. Less than a month later, the president, chief executive officer and chairman of the board, Remi Barbier, resigned along with Lindsay Burns, his wife, who was the company's senior vice president and Wang's co-author. The U.S. Securities and Exchange Commission filed fraud charges in September 2024 against Barbier, Burns and Wang. The parties did not admit wrongdoing, but agreed to pay fines of the company $40 million, Barbier $175,000, Burns $85,000, and Wang $50,000. The DOJ dropped the fraud charges against Wang shortly before trial was scheduled to begin in October 2025 without giving a reason. Wikipedia
Tungkol sa Filana Therapeutics Inc
CEO-
Mga Empleyado19
Itinatag1998
HeadquartersAustin, Texas, Estados Unidos
Sektor-
Website-
Mga nakaraang ulatLahat ng value sa USD
Loading Previous Earnings...
Statement ng kita
Kita
Net na kita
Lahat ng value sa USD
Mar 2025
Hun 2025
Set 2025
Dis 2025
Kita
-
-
-
-
Gastusin sa mga naibentang produkto
13.67M
5.12M
3.96M
3.85M
Halaga ng kita
13.67M
5.12M
3.96M
3.85M
Mga gastos sa pananaliksik at pag-develop
-
-
-
-
Kabuuang gastos sa pananaliksik at pag-develop
-
-
-
-
Mga gastos sa pagbebenta, pangkalahatan, at admin
7.92M
8.98M
7.90M
5.70M
Gastos sa pagpapatakbo
7.92M
8.98M
7.90M
5.70M
Kabuuang gastos sa pagpapatakbo
21.59M
14.09M
11.86M
9.55M
Kita sa pagpapatakbo
-21.59M
-14.09M
-11.86M
-9.55M
Iba pang hindi kita sa pagpapatakbo
-82.00K
-46.00K
-114.00K
39.00K
EBT na may mga hindi karaniwang item
-23.40M
-44.22M
-10.81M
-12.54M
EBT na hindi kasama ang mga hindi karaniwang item
-20.40M
-12.92M
-10.81M
-8.54M
Gastos sa buwis sa kita
-
-
-
-
Epektibong rate ng buwis
-
-
-
-
Iba pang gastos sa pagpapatakbo
-
-
-
-
Net na kita
-23.40M
-44.22M
-10.81M
-12.54M
Margin ng kabuuang kita
-
-
-
-
Kita bawat share
-
-
-
-
Kita sa interes at investment
1.26M
1.21M
1.17M
974.00K
Gastos sa interes
-
-
-
-
Mga net na gastos sa interes
1.26M
1.21M
1.17M
974.00K
Mga singil sa depreciation at amortization
-
-
-
-
EBITDA
-21.37M
-13.87M
-11.73M
-9.18M
Kita o pagkalugi mula sa pagbebenta ng mga asset
-
-
-
-
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa

Pananaliksik

Mga gawain ko
Wala ka pang nagagawang gawain
Lalabas dito ang iyong mga gawain. Mag-iskedyul ng mga gawain at gamitin ang Google Finance habang wala ka.
Mga Template
Briefing ng watchlist
Pang-araw-araw na pagsusuri sa iyong watchlist bago magbukas ang market
Mga Paparating na Kita
Mga paparating na ulat ng mga kita sa linggo
Abnormal na Volatility at Dami
Maagang babala sa volatility at dami ngayong araw
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa